Adrenaline: alerts, information and stock update
19th February 2019
This page will be regularly updated.
Adrenaline news
***URGENT ALERT: Interim protocol for AAI to be stopped from 29 November 2018***
England:
- DHSC update 29 November 2018
- Historical: NPA update 8 November 2018, NPA member news, Department of Health and Social Care and NHS England “Interim protocol on dispensing of adrenaline auto-injectors, 150microgram” and “Pharmacy and Dispensing Practice Q&A regarding EpiPen® and EpiPen® Junior Supply issue”, NHS England letter to all patients/users of Epipen®Junior auto-injector 150mcg (shared through GPs)
Northern Ireland:
- Department of Health update 7 December 2018
- Historical: NPA member news, “Shortages of adrenaline auto-injectors 150microgram“
Scotland:
- Scottish Government PCA (P)(2018) 20 – “Update to protocol on dispensing of adrenaline quti-injectors 150mcg“
- Historical: NPA member news, Scottish Government “Interim Protocol on Dispensing of Adrenaline Auto-injectors, 150mcg” and “Adrenaline for anaphylaxis kits – a reminder to Healthcare Professionals”
Wales:
- NHS Wales: Public Health Link – “Update on protocol on dispensing adrenaline auto-injectors“
- Historical: NHS Wales “Update: Epipen® Junior (Adrenaline Auto-injector Devices) – Supply Disruption – Validation Protocols“
***Latest NPA adrenaline news***
- Urgent: The adrenaline auto-injectors 150mcg protocol is to be stopped from 29 November 2018
- NPA news and updates
- Administration of adrenaline SOP
- Epipen® and Epipen® Junior – changes to instructions for use
***MHRA CAS alerts***
- Historical: 15 October 2018: Update: EpiPen and EpiPen Junior (adrenaline auto-injector devices) – Supply Disruption – this includes the letter which GPs should share with patients/parents/carers of those prescribed EpiPen
- Historical: 28 September 2018: EpiPen and EpiPen Junior – Supply disruption
***The Green Book: Chapter 8 details content of an anaphylaxis kit***
Adrenaline auto-injectors stock update
Pharmacy contractors and their teams can use the following information whilst facing difficulty in obtaining many brands of adrenaline auto-injectors (AAI) from their regular wholesalers.
Please note that availability status changes rapidly and the information is correct at the time of publishing.
Please contact the NPA Pharmacy team on 01727 891 800 or email pharmacyservices@npa.co.uk for further information.
**Latest adrenaline news: EpiPen® 300mcg extended use beyond expiry dates for specific lots numbers
Table 1: availability of adrenaline solution for injection pre-filled disposable devices
| Brand and strength | Pack size(s) | Manufacturer | Next availability update | Last checked |
| Emerade 150mcg/0.15ml (1 in 1000) | 1 |
Bausch & Lomb U.K LimitedTelephone: 0208781 2991 |
|
19 February 2019 |
| Emerade 300mcg/0.3ml (1 in 1000) | 1 |
Bausch & Lomb U.K LimitedTelephone: 0208781 2991 |
|
19 February 2019 |
| Emerade 500mcg/0.5ml (1 in 1000) | 1 |
Bausch & Lomb U.K LimitedTelephone: 0208781 2991 |
|
19 February 2019 |
| EpiPen® Jr. 150mcg/0.3ml (1 in 1000) | 1 and 2 |
Mylan Products LimitedTelephone: 01707 853 000 |
|
19 February 2019 |
| EpiPen® 300mcg/0.3ml (1 in 1000) | 1 and 2 |
Mylan Products LimitedTelephone: 01707 853 000 |
|
19 February 2019 |
| Jext 150mcg/0.15ml (1 in 1000) | 1 |
ALK-Abello LtdTelephone: 0118 903 7940
|
|
19 February 2019 |
| Jext 300mcg/0.3ml (1 in 1000) | 1 |
ALK-Abello LtdCustomer Care: 0118 903 7940 |
|
19 February 2019 |